Stay updated on Regeneron Press Releases
Sign up to get notified when there's something new on the Regeneron Press Releases page.

Latest updates to the Regeneron Press Releases page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedTwo new press releases were added to the page—one announcing investor conference presentations and another detailing Pasatru’s FDA-approved trial results—highlighting fresh investor-focused news. Older May 2026 entries were removed, reflecting archival cleanup of outdated items.SummaryDifference6%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedNew items added to the press releases list include Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation (July 31, 2026) and Regeneron Reports Second Quarter 2026 Financial and Operating Results (July 30, 2026). Older entries were removed (May 15 and May 8, 2026), reflecting an updated, chronological feed on the page.SummaryDifference6%

- Check71 days agoChange DetectedTwo new press releases were added (Q2 2026 financial results and Cemdisiran regulatory submissions). Two older items were removed (Dupixent EoE Phase 4 update and Q1 2026 results).SummaryDifference6%

- Check78 days agoChange DetectedNavigation now shows 'Events & Presentations' and 'Stock Information' as dedicated items, consolidating related investor resources. This changes how users access press releases, events, and stock details from the page.SummaryDifference1%

- Check85 days agoChange DetectedThe press releases list now shows fewer navigation cues because two pagination chevrons (» and ›) were removed. This may affect navigating to older releases, though it does not alter the content of the releases themselves.SummaryDifference0.6%

- Check93 days agoChange DetectedAdded a new press release item titled 'Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO' dated June 4, 2026 7:00 AM EDT. Removed the previously listed press release 'Regeneron Announces Agreement with U.S. Government to Help Lower Drug Costs for American Patients and Will Provide Innovative New Gene Therapy for Free in the U.S.' dated April 23, 2026 3:46 PM EDT.SummaryDifference2%

Stay in the know with updates to Regeneron Press Releases
Enter your email address, and we'll notify you when there's something new on the Regeneron Press Releases page.